The Syndrome of the “Coup de Fouet” Is It Always a Benign Disease?

Author： ANTIGNANI PIER LUIGI TODINI ANNA RITA FORTUNATO TIZIANA BARTOLO MAURO

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.21, Iss.10, 1995-10, pp. : 872-875

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Benign Prostatic Hyperplasia in Patients with Cardiovascular Disease

By Santillo Vincent M. Lowe Franklin C.

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 795-805

Adis International

Access to resources Recommend Favorite

The use of radioiodine in the management of benign thyroid disease

By Weetman Tony

Clinical Medicine, Vol. 7, Iss. 3, 2007-06 ,pp. : 214-215

Royal College Of Physicians

Access to resources Recommend Favorite

Metabolic syndrome: a brain disease

By Gupta Siddharth Dherange Parinita De Meester Fabien Wilczynska Agnieszka Alam Shaan E. Pella Daniel Wilson Douglas W.

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 9, 2012-09 ,pp. : 1171-1183

NRC Research Press

Access to resources Recommend Favorite

Tamsulosin and floppy iris syndrome in benign prostatic hyperplasia patients

By Tiwari Atul

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 4, 2006-04 ,pp. : 443-446

Informa Healthcare

Access to resources Recommend Favorite

Transforming Growth Factor Beta Two in Benign and Malignant Prostate Disease

By Walsh K. Dew T. Sriprasad S. Sherwood R. Mulvin D.

UroOncology, Vol. 2, Iss. 3, 2003-07 ,pp. : 113-115

Ashgate Publishing Ltd

Access to resources Recommend Favorite